Cargando…
Nifurtimox Inhibits the Progression of Neuroblastoma in vivo
Neuroblastoma was one of the most life-threatening cancer developed in children, yet the conventional therapies currently used leave an unmet gap for clinical requirements. Temozolomide is the first line of drug in the treatment of neuroblastorma nowadays. Giving the fact that temozolomide treatment...
Autores principales: | Kong, Eryan, Zhu, Jiangli, Wu, Wentao, Ren, Hongguang, Jiao, Xuemiao, Wang, Hui, Zhang, Zhongjian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584410/ https://www.ncbi.nlm.nih.gov/pubmed/31258723 http://dx.doi.org/10.7150/jca.27851 |
Ejemplares similares
-
Structural
and Mechanistic Investigation of the Unusual
Metabolism of Nifurtimox
por: Lang, Dieter, et al.
Publicado: (2022) -
In vivo Metabolism of Nifurtimox and the Drug-Drug Interaction Potential Including its Major Metabolites
por: Schulz, Simone I., et al.
Publicado: (2023) -
Correction
to “Structural and Mechanistic Investigation
of the Unusual Metabolism of Nifurtimox”
por: Lang, Dieter, et al.
Publicado: (2023) -
Protocol to quantify palmitoylation of cysteines in budding yeast
por: Lei, Yuqing, et al.
Publicado: (2021) -
Safety Profile of Nifurtimox for Treatment of Chagas Disease in the United States
por: Forsyth, Colin J., et al.
Publicado: (2016)